Delivery Order SPE2DB22D1202-SPE2DB25FVHV0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 1 mg/ml ampules. This non-set-aside, competitively awarded contract is valued at $1,699.56 with a firm fixed price and an ultimate completion date of July 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This non-competitive delivery order, issued on August 5, 2025, represents a firm fixed-price purchase under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with a contract ceiling value of $1,800.50. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. The performance location is established at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with a contract ceiling value of $2,078.12. The award, issued on August 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. Performance will be executed from the company's location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating the award resulted from open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed-price contract valued at $1,191.06. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $1,160.25 to AmerisourceBergen Drug Corp for pre-filled epinephrine ampules (0.25 mL) on August 5, 2025, with completion scheduled for August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $16,667.20 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with an ultimate completion date of August 12, 2025. This firm fixed price contract was competitively awarded without set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,054.16 on July 28, 2025, for the supply of Epinephrine 1 mg/mL ampules. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 29, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department organization...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,856.40. This competitively awarded, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs under a firm fixed-price contract structure. The order, valued at $15,123.04, will be completed by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHV0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Epinephrine 1 mg/mL ampules, valued at $1,311.41. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for completion by August 21, 2025, reflecting the expedited nature of pharmaceutical supply chain support for federal medical needs. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide range of medications and medical supplies to support military healthcare systems globally. The epinephrine delivery aligns with the broader pharmaceutical support mission, providing critical emergency medications essential for military medical readiness and healthcare operations across the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/20/25 |